JAZZ News and Press, Jazz Pharmaceuticals plc

A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 38.2% to $0.24 on volume of 498,894,705 shares Qualigen Therapeutics Inc. (QLGN) rose 59.5% to $0.28 on volume of 243,116,946 shares NVIDIA Corporation (NVDA) fell 1.9% to $125.83 on volume o...

A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 109.0% to $0.3668 on volume of 102,385,159 shares Maxeon Solar Technologies Ltd. (MAXN) rose 4.3% to $0.181 on volume of 66,422,365 shares NVIDIA Corporation (NVDA) fell 1.3% to $126.58 on volume...

A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 4.6% to $128.28 on volume of 215,349,874 shares Zoomcar Holdings Inc. (ZCAR) rose 34.0% to $0.183 on volume of 204,010,215 shares Maxeon Solar Technologies Ltd. (MAXN) fell 3.5% to $0.1736 on volume of 2...

2024-06-21 14:41:42 ET More on Praxis Precision Medicines Praxis: 2nd Half 2024 ET Readout Could Lead To U.S. Regulatory Filing Praxis Precision Medicines announces proposed public offering Praxis gains after mid-stage data for epilepsy candidate Seeking Alph...

2024-06-21 09:15:24 ET Summary Jazz Pharmaceuticals plc's suvecaltamide failed in a phase 2b trial for essential tremor, but this is a minor setback for the company and one that should have been expected. The oxybate franchise is performing well despite generic Xyrem and Lumryz co...

2024-06-20 08:14:15 ET More on Jazz Pharmaceuticals Jazz Pharmaceuticals plc (JAZZ) Q1 2024 Earnings Call Transcript Jazz Pharmaceuticals plc 2024 Q1 - Results - Earnings Call Presentation Jazz Pharmaceuticals: Cheap But Complicated Goldman starts Jazz at buy...

Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor PR Newswire DUBLIN , June 20, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced top-line results from the Phase ...

2024-06-17 10:45:03 ET DMC Global Inc (BOOM) BOOM is trading UP for the last 5 days, and it at trading at $14.55 with volume of 123,360 and a one day change of $0.12 (0.83%). DMC Global Inc has a 52-week low of 11.12 and a 52-week high of $27.16. The business's 50-day moving average...

2024-06-16 10:38:06 ET Summary Avadel Pharmaceuticals is a small-cap biopharma company headquartered in Dublin, Ireland. The company's primary asset is LUMRYX, which has the potential to be a 'best of breed' compound in a large market. Currently, Avadel is locked in a pivotal ...

2024-06-14 06:13:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips If this year’s market volatility has left you reeling, you’re not alone. But, despite the high valuations plaguing many tech stocks , plenty of top-tier, high-quality blue-c...